Reports

Global Argatroban Market Data Survey Report 2015-2025

Summary Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35. The global Argatroban market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales data and product specifications etc.: Pfizer SANDOZ GlaxoSmithKline fresenius-kabi Eagle Pharmaceuticals Mitsubishi Tanabe Pharma Teva Pharmaceutical Industries WEST-WARD Major applications as follows: Heparin-induced thrombocytopenia (HIT) Percutaneous Coronary Intervention Cerebral arterial thrombosis Major Type as follows: Argatroban Powder Argatroban Injection Regional market size, production data and export & import: Asia-Pacific North America Europe South America Middle East & Africa

Last updated 12-30-2019 Read More